Literature DB >> 25014238

Outcomes of patients with acute upper gastrointestinal nonvariceal hemorrhage referred to interventional radiology for potential embolotherapy.

Onur Sildiroglu1, Jamil Muasher, Bulent Arslan, Saher S Sabri, Wael E Saad, John F Angle, Alan H Matsumoto, Ulku C Turba.   

Abstract

PURPOSE: To report the outcomes following catheter angiography with or without embolization in patients with acute upper gastrointestinal nonvariceal hemorrhage (UGINH).
MATERIALS AND METHODS: A review of electronic medical records was performed to identify all potential patients for this study between 2001 and 2011. Patients with first-time UGINH who required angiographic localization and endovascular treatment were included. Patients with variceal bleeding and prior surgical or endovascular intervention for the gastrointestinal system were excluded. Society of Interventional Radiology guidelines and American College of Radiology "appropriateness criteria" reporting standards were followed.
RESULTS: We identified 74 patients (men/women=46/28) with a mean age of 60 years. Thirty-four patients were found to have active bleeding on angiography. One patient from this group did not undergo embolization because of an angiographic diagnosis of aortoenteric fistula. Technical failure was encountered in 2/34 patients; therefore, the technical success of embolization was 94%. Forty of 74 patients showed no angiographic evidence of active bleeding; 18 patients underwent prophylactic embolization using endoscopically placed clips as targets; and 22 patients had no embolotherapy. Thus, we grouped the patients into 3 groups: (1) therapeutic embolization; (2) prophylactic/empiric embolization; and (3) no embolotherapy groups. The clinical success of embolization was 67% to 68% in the therapeutic embolization group and 67% in the prophylactic embolization group. Early rebleeding rates were 33.8%, 51.6%, 33.3%, and 12% among all the patients, the therapeutic embolization group, the prophylactic embolization group, and the no endovascular treatment group, respectively. Mortality was significantly high in patients with advanced age (P=0.001), cerebrovascular disorders (P=0.037), and positive angiography (P=0.026), even when clinical success was achieved.
CONCLUSIONS: Acute UGINH remains a clinical challenge with increased mortality rates, even with high technical success rates. Patients with negative findings on angiography have lower early rebleeding rates than patients with active bleeding during angiography or endoscopy-guided prophylactic/empiric embolization.

Entities:  

Mesh:

Year:  2014        PMID: 25014238     DOI: 10.1097/MCG.0000000000000181

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  Transarterial embolisation for gastroduodenal bleeding following endoscopic resection.

Authors:  Suyoung Park; Boryeong Jeong; Ji Hoon Shin; Eun Ho Jang; Jung Han Hwang; Jeong Ho Kim
Journal:  Br J Radiol       Date:  2021-04-16       Impact factor: 3.629

2.  Rockall Score Larger Than 7 as a Reliable Criterion for the Selection of Indications for Preventive Transarterial Embolization in a Subgroup of High-Risk Elderly Patients After Primary Endoscopic Hemostasis for Non-Variceal Upper Gastrointestinal Bleeding.

Authors:  Aleksejs Kaminskis; Patricija Ivanova; Sanita Ponomarjova; Maksims Mukans; Viesturs Boka; Guntars Pupelis
Journal:  Gastroenterology Res       Date:  2018-01-03

Review 3.  Complementary roles of interventional radiology and therapeutic endoscopy in gastroenterology.

Authors:  David M Ray; Indu Srinivasan; Shou-Jiang Tang; Andreas S Vilmann; Peter Vilmann; Timothy C McCowan; Akash M Patel
Journal:  World J Radiol       Date:  2017-03-28

4.  Peptic Ulcer Is the Most Common Cause of Non-Variceal Upper-Gastrointestinal Bleeding (NVUGIB) in China.

Authors:  Mingliang Lu; Gang Sun; Xiao-Mei Zhang; You-Qing Xv; Shi-Yao Chen; Ying Song; Xue-Liang Li; Bin Lv; Jian-Lin Ren; Xue-Qing Chen; Hui Zhang; Chen Mo; Yan-Zhi Wang; Yun-Sheng Yang
Journal:  Med Sci Monit       Date:  2018-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.